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Integrin signaling modulates trophoblast adhesion to extracellular matrices during blastocyst implantation. Fibronectin (FN)-binding activity
on the apical surface of trophoblast cells is strengthened after elevation of intracellular Ca2+ downstream of integrin ligation by FN. We report here
that phosphoinositide-specific phospholipase C (PLC) mediates Ca2+ signaling in response to FN. Pharmacological agents used to antagonize PLC
(U73122) or the inositol phosphate receptor (Xestospongin C) inhibited FN-induced elevation of intracellular Ca2+ and prevented the upregulation
of FN-binding activity. In contrast, inhibitors of Ca2+ influx through either voltage-gated or non-voltage-gated Ca2+ channels were without effect.
Inhibition of protein tyrosine kinase activity by genistein, but not G-protein inhibition by suramin, blocked FN-induced intracellular Ca2+
signaling and upregulation of adhesion, consistent with involvement of PLC-γ. Confocal immunofluorescence imaging of peri-implantation
blastocysts demonstrated that PLC-γ2, but not PLC-γ1 nor PLC-β1, accumulated near the outer surface of the embryo. Phosphotyrosine site-
directed antibodies revealed phosphorylation of PLC-γ2, but not PLC-γ1, upon integrin ligation by FN. These data suggest that integrin-mediated
activation of PLC-γ to initiate phosphoinositide signaling and intracellular Ca2+ mobilization is required for blastocyst adhesion to FN. Signaling
cascades regulating PLC-γ could, therefore, control a critical feature of trophoblast differentiation during peri-implantation development.
© 2006 Elsevier Inc. All rights reserved.Keywords: Blastocyst implantation; Trophoblast; Phospholipase C; Ca2+ signaling; Signal transduction; Integrins; Fibronectin; Extracellular matrix; Cell adhesion;
Tyrosine phosphorylationIntroduction
Blastocyst implantation in mice and humans depends on the
interaction of differentiated, adhesion-competent trophoblast cells
with extracellular matrix (ECM) components of the receptive
uterus (Carson et al., 2000; Wang and Armant, 2002; Armant,
2005). Achievement of the adhesion-competent stage by mouse
blastocysts correlates with trafficking of α5β1 integrins and the
concomitant acquisition of fibronectin (FN)-binding activity on the
apical surface of trophoblast cells (Schultz and Armant, 1995;
Schultz et al., 1997). Blastocysts developing to the adhesion-
competent stage exhibit strong FN-binding activity only after
exposure to FN or an active fragment, FN-120, through a process
dependent on energy, intracellular trafficking and actin microfil-
ament integrity, but requiring no new protein synthesis (Schultz⁎ Corresponding author. Fax: +1 313 577 8554.
E-mail address: D.Armant@wayne.edu (D.R. Armant).
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doi:10.1016/j.ydbio.2006.09.015and Armant, 1995). The strengthening of trophoblast adhesion to
FN is mediated by ligation of integrins that contain the α5, αv, β1
and β3 subunits and is strongly correlated with subsequent
trafficking of the αIIb integrin subunit to the apical plasma
membrane (Wang et al., 2002; Rout et al., 2004). Therefore, both
“outside-in” and “inside-out” integrin signaling (Burridge and
Chrzanowska-Wodnicka, 1996; Aplin et al., 1998; Giancotti and
Ruoslahti, 1999) appear to be required by trophoblast cells in order
to achieve strong adhesion to FN and progress through the peri-
implantation developmental program (Armant, 2005). Evidence
suggests that α5β1 is primarily responsible for outside-in
signaling, while inside-out signaling positions αIIbβ3 on the
surface of the blastocyst to strengthen adhesion (Rout et al., 2004).
Integrin ligation by FN transiently elevates intracellular Ca2+
levels in mouse blastocysts and interference with this Ca2+
signaling blocks the upregulation of FN-binding activity (Wang
et al., 2002). Conversely, direct elevation of intracellular Ca2+ with
ionomycin strengthens trophoblast adhesion to FN to the same
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integrin-mediated signal transduction has been described in several
cell types. Mobilization of intracellular Ca2+ followed by protein–
tyrosine phosphorylation occurs when cells expressing αIIbβ3
integrin adhere to FN or fibrinogen (Pelletier et al., 1992). Signal
transduction stimulated in endothelial cells also involves an inter-
action between integrins present in focal adhesion complexes and
the Ca2+-dependent kinases, protein kinase C (PKC) and Ca2+-
calmodulin-dependent protein kinase (Berk et al., 1995). Ca2+-
related transducers of intracellular signaling, including inositol
1,4,5 trisphosphate (Ins(1,4,5)P3)-specific phospholipase C (PLC)
and PKC, are recruited to the plasma membrane by α5β1 integrins
when ligated by either FN or specific antibodies (Miyamoto et al.,
1995). In adhesion-competent trophoblast cells, elevation of
intracellular Ca2+ to strengthen trophoblast adhesion to FN
appears to require the downstream factors, PKC and calmodulin
(Wang et al., 2002). How intracellular Ca2+ signaling is initiated
by integrin ligation in mouse blastocysts has not been delineated.
Mechanisms responsible for elevation of intracellular Ca2+
include (1) release from intracellular stores through either the Ins
(1,4,5)P3 or ryanodine receptors, (2) influx through voltage-
gated Ca2+ channels and (3) capacitative Ca2+ entry, in which
Ca2+ influx occurs subsequent to the release of intracellular Ca2+
stores (store-operated Ca2+ entry) (Putney et al., 2001). Integrin
ligation can elevate intracellular Ca2+ levels through Ca2+ influx
(Leavesley et al., 1993; Schwartz, 1993), activation of PLC to
generate Ins(1,4,5)P3 and mobilize intracellular Ca
2+ stores
(Somogyi et al., 1994; Chan et al., 2001), or initiation of
capacitative Ca2+ influx (Schottelndreier et al., 2001). The
capacity for both Ca2+ influx and mobilization of intracellular
Ca2+ stores exist in mouse preimplantation embryos. During
early preimplantation development, the activities of PLC and the
Ins(1,4,5)P3 receptor are operative during capacitative Ca
2+
entry in response to platelet activation factor (Emerson et al.,
2000). Evidence also exists for the presence of Ins(1,4,5)P3-
sensitive intracellular Ca2+ stores at the 8-cell and blastocyst
stages (Stachecki and Armant, 1996; Liu and Armant, 2004),
and Ca2+ influx through L- and N-type voltage-gated calcium
channels after stimulation by cannabinoids or heparin-binding
EGF-like growth factor (HBEGF), respectively, at the blastocyst
stage (Wang et al., 2003; Wang et al., 2000b). In the present
study, we have examined the mechanism underlying integrin-
mediated Ca2+ mobilization in adhesion-competent trophoblast
cells during a period when these cells differentiate from an
epithelial phenotype into motile, invasive cells.
Materials and methods
Production and culture of mouse embryos
Female NSA or MF1 mice (Harlan Sprague–Dawly, Indianapolis, IN)
5–8 weeks old were superovulated, as previously described (Armant, 2006).
Eggs were recovered by flushing oviducts with M2 medium (Sigma Chemical
Company, St Louis, MO) the morning after injection of human chorionic
gonadotropin. For generation of embryos, female mice were mated with
B6SJLF1/J males (Jackson Laboratory, Bar Harbor, ME) and embryos were
collected by flushing the oviducts with M2 on gestation day (GD) 1–3 or the
uterus on GD 4 (where GD1 is the day of the vaginal plug), as previously
described (Armant, 2006). All experiments using adhesion-competent blas-tocysts were conducted by first culturing blastocysts from GD 4 to GD 7 in
Ham's F10medium containing 4mg/ml BSA, 100U/ml penicillin and 0.1mg/ml
streptomycin (all from Sigma) at 37°C in a 5% CO2/air incubator.
Preparation of cell extracts
Monolayers of mouse B16-F10 melanoma cells (American Type Culture
Collection, Rockville, MD), mouse trophoblast stem (TS) cells and human
HTR-8/Svneo cytotrophoblast cells were grown as previously described (Yelian
et al., 1995; Kilburn et al., 2000; Tanaka et al., 1998) and harvested in SDS
sample buffer containing 1 mM sodium orthovanadate, and protease inhibitors
(1 mM PMSF, 25 KIU/ml aprotinin, 2 μM leupeptin, 2 μM antipain, 10 μM
benzamidine, 1 μM pepstatin and 1 μM chymostatin; all from Sigma). Mouse
spleen was cut into small pieces, rinsed in ice-cold PBS three times and
dissociated to prepare a single cell suspension using a Polytron (Omni
International, Inc. Waterbury, CT) at 7500 rpm. Spleen cells were collected by
centrifugation at 1000×g and rinsed three times using cold PBS. Cells were
lysed using cold NP-40 lysis buffer (137 mM NaCl, 20 mM Tris, 1% NP-40,
10% glycerol, pH 8.0) containing orthovanadate and protease inhibitors
described above. After centrifuging at 13,000×g for 3 min, the supernatant
was recovered and the protein concentration was determined using a Bio-Rad
(Rockville Center, NY) DC protein assay kit.
FN-binding activity
FN-binding activity was upregulated by exposing blastocysts to 50 μg/ml
FN-120 for 1 h, as previously described (Wang et al., 2000b; Armant, 2006). In
some experiments, the blastocysts were treated at 37°C for 1 h before and during
exposure to FN-120 by addition of the following inhibitors to the culture
medium: 10 μM U73122, 10 μM U73343, 1 μM Xestospongin C, 10 μM
flunarizine, 10 μMbepridil, 10 μM genistein, 10 μMdaidzein or 10 μM suramin
(all from EMD Biosciences, Inc., San Diego, CA). Similar treatments were also
carried out using 2 μM FTX-3.3, 3 μM ω-conotoxin GVIA, 1 μM ω-conotoxin
MVIIC or 1 μM calciseptine (all from Alomone Labs, Jerusalem, Israel).
FN-binding activity was assayed, as previously described (Schultz and
Armant, 1995; Armant, 2006), using 1.0 μm fluorescent-green polystyrene
microspheres (Polyscience) coated with FN-120. The fluorescence intensity of
the bound microspheres was quantified over the abembryonic pole of each
blastocyst using computer-based image analysis, as described by Schultz and
Armant (1995). Basal FN-binding activity, determined by exposing embryos to
BSA in place of FN-120, was subtracted from all values obtained with embryos
exposed for 1 h to 50 μg/ml FN-120. The derived change (Δ) in FN-binding
activity value was normalized to the mean control values obtained in each
experiment and reported as mean±SEM.
Intracellular Ca2+ measurements
For estimation of the intracellular Ca2+ concentration, blastocyst cells loaded
for 1 h with 5 μM fluo-3-acetoxymethyl ester (fluo-3-AM) or fluo-4-AM
(Molecular Probes, Inc., Eugene, OR) were subjected to epifluorescence
microscopy and image analysis, as previously described (Wang et al., 1998).
After dye loading, some embryos were treated for 15 min with 2 μM FTX-3.3,
3 μM ω-conotoxin GVIA, 1 μM ω-conotoxin MVIIC, 1 μM calciseptine,
10 μM flunarizine, 10 μM bepridil, 10 mM NiCl2, 10 μM caffeine (Sigma),
10 μM thapsigargin (EMD Biosciences), 10 μMU73122, 10 μMU73343, 1 μM
Xestospongin C, 10 μM genistein or 10 μM daidzein. Embryos were imaged
individually at 37°C in 5 μl drops of culture medium with or without 50 μg/ml
FN-120 on Petri-dishes flooded with mineral oil. To monitor Ca2+ mobilization,
embryos were briefly illuminated every 0.25 min for fluorescence imaging. All
data presented depict single embryos that are representative of a minimum of 10
embryos for each treatment.
Immunological identification of PLC isoforms
Immunological procedures were conducted using polyclonal antibodies that
recognize specific PLC isoforms. Rabbit IgGs recognizing PLC-β1 (G-12),
PLC-γ1 (530) or PLC-γ2 (Q-20) were obtained from Santa Cruz Biotechnology,
Table 1
Influence of voltage-gated Ca2+ channel blockers on upregulation of FN-binding
activity and increased cytoplasmic Ca2+ in blastocysts treated with FN-120
Ca2+ channel blockers Channel type ΔFN-binding activity a
(% of control)
Ca2+ elevated b
Control 99.9±15 Yes
2 μM FTX-3.3 P-/Q- 90.0±15 Yes
1 μM ω-conotoxin
MVIIC
Q- 102±18 Yes
3 μM ω-conotoxin
GVIA
N- 110±15 Yes
1 μM calciseptine L- 71.3±16 Yes
10 μM flunarizine T- 73.4±10 Yes
10 μM bepridil T- 73.1±20 Yes
Blastocysts were treated with 50 μg/ml FN-120 in the absence (Control) or
presence of the indicated inhibitors and assayed for ΔFN-binding activity and
Ca2+ signaling, as detailed in Materials and methods.
a Values (mean±SEM) were not significantly different according to ANOVA.
b Intracellular Ca2+ increased from about 200 nM to at least 365 nM after
adding FN-120 where scored as elevated. At least 10 embryos all tested
positively for each treatment.
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detected using antibodies that recognize specific tyrosine-phosphorylated
epitopes. PLC-γ1 phosphorylated at tyrosine 783 was labeled using either a
goat antibody (Tyr 783) from Santa Cruz or a rabbit antibody (Tyr783) from Cell
Signaling Technologies, Inc. (Danvers, MA). PLC-γ2 phosphorylated at
tyrosine 1217 was labeled with a rabbit antibody (Tyr1217) from Cell Signaling.
For immunofluorescence microscopy, blastocysts were fixed at room
temperature for 30 min in 3% paraformaldehyde, washed through 2 drops of
150 mM glycine, pH 7.2 and permeabilized by treatment with 0.1% Triton ×100
(Sigma) for 15 min at room temperature. Five drops of PBS containing 10 mg/ml
BSA (PBS/BSA) were used to rinse embryos after all incubations throughout the
procedure. Blastocysts were incubated overnight at 4°C with primary antibodies
prepared at 10 μg/ml in PBS/BSA. As primary antibody controls, some embryos
were incubated with 10 μg/ml non-immune rabbit IgG (Jackson ImmunoR-
esearch Laboratories, West Grove, PA). Primary antibodies were detected using
10 μg/ml Texas-Red-conjugated goat anti-rabbit IgG (Jackson Immunoresearch)
incubated with embryos at room temperature for 1 h.
For confocal imaging, Texas-Red-labeled blastocysts were mounted on
slides with permanent mounting medium (Chemicon, Temecula, CA) and
stored at 4°C. Embryos were viewed on a Zeiss (Thornwood, NY) 310
confocal scanning laser microscope, using identical contrast and gain settings
to generate all images. Blastocysts labeled with anti-phospho-PLC antibodies
were viewed using epifluorescence microscopy (Leica DM IRB; Wetzlar,
Germany). Images captured with an Orca digital camera (Hamamatsu City,
Japan) were deconvolved from 1 μm serial optical sections using SimplePCI
(C-Imaging system, Cranberry Township, PA) imaging software and a “nearest
neighbor” algorithm. The fluorescence intensities of labeled blastocysts were
quantified from these images using SimplePCI software, which measured the
total fluorescence (grey level) of an area at the outer edge of each embryo
delineated within a digital image. The mean intensity of control embryos
exposed to FN-120 for 30 min and labeled with non-immune IgG was
subtracted from the intensity for each embryo to derive the specific phospho-
PLC staining intensity.
Western blotting was used to validate all primary antibodies. Proteins
extracted from B16, TS, HTR-8/Svneo and mouse spleen cells were diluted in
SDS sample buffer (125 mM Tris, pH 6.8, 4% SDS, 10% glycerol, 0.006%
bromophenol blue, 2% β-mercaptoethanol) and electrophoresed (30 μg/lane)
on a 7.5% SDS polyacrylamide gel. Separated proteins were then transferred
electrophoretically from the gel to polyvinylidene difluoride or nitrocellulose
membranes (Millipore, Burlington, MA), and blocked overnight at room
temperature with 5% (w/v) nonfat dry milk prepared in PBS. Membranes
were incubated overnight at 4°C with 1 μg/ml primary antibody diluted in
TTBS (20 mM Tris–HCl, pH 7.6, 145 mM NaCl and 0.1% Tween-20)
containing 1% nonfat dry milk. After rinsing three times with TTBS, the
membranes were incubated for 1 h at room temperature with 1:3000
horseradish peroxidase-conjugated donkey anti-rabbit IgG (Jackson Immu-
noResearch) in TTBS/1% nonfat dry milk. After three rinses in TTBS, the
probe was visualized using enhanced chemiluminensence, as previously
described (Kilburn et al., 2000).
Statistical analysis
All experiments were repeated at least three times. Values reported for FN-
binding activity were obtained using at least 15 blastocysts per treatment group.
Differences between treatment groups in the FN-binding activity and PLC
staining intensity were tested for significance using a one-way ANOVA and the
Bonferroni/Dunn post hoc test.
Results
Upregulation of FN-binding activity does not depend on Ca2+
influx
To investigate whether FN-120 induces an intracellular Ca2+
transient in blastocysts by initiating Ca2+ influx through voltage-
gated Ca2+ channels, we have examined the effects of Ca2+channel (L-, N-, P-, Q- or T-type) blockers on FN-120-mediated
Ca2+ signaling and upregulation of FN-binding activity. A
similar approach was used previously for blastocysts treated
with HBEGF to demonstrate that inhibitors of N-type Ca2+
channels significantly attenuate the acceleration of development
(Wang et al., 2000b). None of the blockers tested significantly
inhibited the ability of FN-120 to induce a Ca2+ transient or
upregulate FN-binding activity (Table 1), suggesting that
voltage-gated Ca2+ channels are not required for integrin
signaling in trophoblast cells.
Integrins can induce Ca2+ influx through non-voltage gated
Ca2+ channels (Schottelndreier et al., 2001). It was considered
inadvisable to chelate extracellular Ca2+ because of possible
interference with integrin binding to FN-120, as found by
Schultz and Armant (1995) using EDTA. As an alternate
approach, Ca2+ influx was inhibited by NiCl2. Blastocysts were
first treated with 10 mM NiCl2 and then exposed to FN-120 in
the continued presence of inhibitor prior to assessing intracel-
lular Ca2+ or FN-binding activity. NiCl2 did not reduce FN-
induced elevation of intracellular Ca2+(Fig. 1) or upregulation
of FN-binding activity (not shown), suggesting that influx of
extracellular Ca2+ is not the primary source for elevation of
intracellular Ca2+ levels during this process.
FN elevates cytoplasmic free Ca2+ through release from Ins
(1,4,5)P3-sensitive Ca
2+ stores
To examine whether FN-120 elevates intracellular Ca2+
through release from intracellular Ca2+ stores, FN-induced Ca2+
signaling was examined in blastocysts treated with either
caffeine or thapsigargin to deplete ryanodine- or Ins(1,4,5)P3-
sensitive intracellular Ca2+ stores, respectively. FN-120 induced
an intracellular Ca2+ transient in caffeine-treated blastocysts,
but not in thapsigargin-treated embryos (Fig. 1), suggesting that
integrin signaling triggered by FN-120 primarily targets Ins
(1,4,5)P3-sensitive intracellular Ca
2+ stores.
Fig. 2. Dependence of FN-induced intracellular Ca2+ signaling on the PLC-Ins
(1,4,5)P3 pathway. Blastocysts were treated with vehicle (Control), 10 μM
U73343, 10 μMU73122 or 1 μMXestospongin C and then exposed to FN-120.
Intracellular Ca2+ levels (A) were monitored and reported as in Fig. 1 and ΔFN-
binding activities (B) were normalized to the Control group and reported as
mean±SEM. *P<0.05, compared to Control.
Fig. 1. Regulation of intracellular Ca2+ downstream of integrin ligation.
Blastocysts were treated with vehicle (Control), 10 mM NiCl2, 10 μM
thapsigargin or 10 μM caffeine and then exposed to 50 μg/ml FN-120 (arrows)
in the continued presence of inhibitor. Intracellular Ca2+ concentration was
monitored by immunofluorescence microscopy, as detailed in Materials and
methods. Each graph depicts the average concentration integrated over an entire
representative embryo.
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activation of PLC
Ins(1,4,5)P3 is produced by activation of phosphoinositide-
specific PLC and the subsequent hydrolysis of phosphatidyli-
nositol 4,5-bisphosphate (Rhee and Bae, 1997). To examine the
role of PLC activity and Ins(1,4,5)P3 signaling after ligation of
integrins by FN, blastocysts were treated before exposure to
FN-120 with 10 μM U73122, a potent inhibitor of phosphoi-
nositide-specific PLC, or 1 μMXestospongin C, an Ins(1,4,5)P3
receptor antagonist (Gafni et al., 1997). Both inhibitors
prevented the appearance of a Ca2+ transient (Fig. 2A) and
blocked the upregulation of FN-binding activity (Fig. 2B),
suggesting that activation of the PLC/Ins(1,4,5)P3 signaling
pathway is required for both events. U73343, a less active
structural analog of U73122, inhibited neither the upregulation
of FN-binding activity nor induction of intracellular Ca2+
transients (Figs. 2A, B). It can be concluded that PLC operates
upstream to Ca2+ mobilization in the integrin signaling pathway
initiated by FN-120.PLC-γ mediates outside-in signaling during upregulation of
FN-binding activity
Six major families of PLC isoforms (PLC-β,-γ,-δ,-ε,-ζ
and -η) have been identified in mammalian tissues that include at
least 13 different isozymes (Rebecchi and Pentyala, 2000;
Harden and Sondek, 2006). PLC-γ isoforms are activated by
protein tyrosine kinases (PTK), while PLC-β, PLC-δ and the
other isoforms are activated through pathways dependent on
heterotrimeric G proteins or small GTPases of the Ras family
(Rebecchi and Pentyala, 2000; Harden and Sondek, 2006). We
have examined the expression of three PLC isozymes in mouse
embryos using antibodies that recognize proteins of the expected
molecular weights and tissue distribution. As expected, PLC-β1
and PLC-γ1 were detected by western blot in melanoma and
trophoblast cells, while PLC-γ2 was only detected in spleen
(Figs. 3A–C). Trophoblast cells in adhesion-competent mouse
blastocysts expressed both PLC-β and PLC-γ isoforms (Fig. 4),
indicating that either a tyrosine kinase or G protein-based PLC-
Fig. 3. Specificity of antibodies against PLC isoforms. Western blotting was
conducted, as described in Materials and methods, using antibodies against
PLC-β1 (A), PLC-γ1 (B) or PLC-γ2 (C). The lanes contained proteins extracted
from human HTR-8/SVneo cytotrophoblast cells (hCT), mouse B16 melanoma
cells (B16), mouse spleen (mS; positive control for PLC-γ2) and a commercial
Jurkat cell lysate preparation (Jurkat; BD Biosciences, San Jose, CA; positive
control for PLC-γ1). In panel D, antibodies against PLC-γ1 (γ1) and PLC-γ2
(γ2) were compared to antibodies recognizing the tyrosine phosphorylated
forms of each enzyme (p-γ1, p-γ2) using a lysate prepared from mouse TS cells.
Molecular weights (kDa) are indicated to the left in each panel.
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mobilization.
In an effort to resolve the principal signaling pathway
upstream to PLC, blastocysts were treated with suramin to
inhibit G-protein activity, as well as genistein to block
activation of PTK. Genistein effectively blocked the elevation
of intracellular Ca2+ induced by FN-120 (Fig. 5A) and the
upregulation of FN-binding activity (Fig. 5B), while the G-
protein inhibitor had no effect on the ability of FN-120 to
upregulate FN-binding activity (Fig. 5C). As a positive control,
suramin blocked the upregulation of FN-binding activity by
lysophosphatidic acid (data not shown), an inducer of Ca2+Fig. 4. Expression of PLC-β1 and PLC-γ1 in adhesion-competent trophoblast ce
immunofluorescence using non-immune IgG (IgG) or antibodies against PLC-γ1 o
sections are shown for antigen visualized using Texas-Red-conjugated secondary anmobilization in blastocysts (Liu and Armant, 2004) that binds to
a G-protein-coupled receptor (van Corven et al., 1989). The less
active structural analogue of genistein, daidzein, did not inhibit
the effects of FN-120 treatment (Figs. 5A, B). These findings
suggest that the PTK-dependent PLC-γ isoforms, but not PLC-
β1 or other G protein-dependent isozymes, are responsible for
Ca2+ signaling during trophoblast interaction with FN.
Expression of PLC-γ during preimplantation development
To delineate the expression of the two PLC-γ isoforms
during mouse preimplantation development, unfertilized eggs
and embryos at the 1-cell stage to the adhesive blastocyst stage
(cultured to GD 7) were assessed by immunofluorescence
labeling and scanning laser confocal microscopy. PLC-γ1, a
ubiquitously expressed isoform (Rebecchi and Pentyala, 2000),
was detected at a relatively high level in unfertilized eggs and
zygotes (Fig. 6A). PLC-γ1 declined during preimplantation
development, with only trace levels observed in adhesion-
competent blastocysts. In contrast, PLC-γ2, which is primarily
expressed in the lymphatic system (Rebecchi and Pentyala,
2000), was highly expressed in preimplantation mouse embryos
(Fig. 6B). Similar to PLC-γ1, high levels of PLC-γ2 were found
in unfertilized eggs and zygotes with decreasing expression
after blastocyst formation. However, a relatively high level of
PLC-γ2 appeared in adhesive blastocysts on GD7 localized
primarily at the apical surface of trophoblast cells, making it
accessible to integrin signaling complexes.
PLC-γ phosphorylation during integrin signaling
Activation of PLC-γ is accomplished through tyrosine
phosphorylation (Harden and Sondek, 2006) and can be
monitored using phosphorylation-specific antibodies. We
examined PLC-γ1 and PLC-γ2 phosphorylation in adhesion-
competent blastocysts during the period immediately following
exposure to FN-120 using antibodies directed against phos-
phorylated tyrosine residues at positions 783 and 1217 in the
respective proteins. Western blotting of mouse TS cell extracts
demonstrated that antibodies against both phosphorylated
proteins specifically detected bands at the expected molecular
sizes, matching antibodies against PLC-γ1 and PLC-γ2 (Fig.
3D). The phosphorylation-specific antibodies were then used tolls. Blastocysts cultured to GD 7 were fixed, permeabilized and labeled by
r PLC-β1, as detailed in Materials and methods. Representative 1 μm optical
tibody and scanning laser confocal microscopy.
Fig. 5. Dependence of FN-induced intracellular Ca2+ signaling on PTK and G-proteins. Blastocysts were treated with 10 μM genistein, daidzein or suramin and then
exposed to FN-120 in the continued presence of the same inhibitor. Embryos treated with vehicle served as controls. Some embryos were not exposed to FN-120 or
inhibitor (BSA). Intracellular Ca2+ levels (A) and ΔFN-binding activities (B, C) were monitored and reported as in Fig. 2. *P<0.05, compared to Control.
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(Fig. 7A). Five minutes after exposure to FN-120, phospho-
PLC-γ1 staining remained at or near background levels, while
phospho-PLC-γ2 labeling became intense near the apical
surface of the trophoblast. Quantification of the fluorescence
intensity indicated no change in PLC-γ1 phosphorylation over a
30-min period; however, phospho-PLC-γ2 labeling increased
significantly within 5 min of FN-120 treatment and continued to
rise over the next 25 min (Fig. 7B). Specific phospho-PLC
staining shown in Fig. 7B was calculated by subtracting the
background staining of non-immune IgG, which was low
(6.0±0.8). While not ruling out a role for PLC-γ1 or other PLC
isozymes, these findings provide strong evidence that PLC-γ2
has a major role in transducing integrin-initiated signals in
mouse trophoblast cells.
Discussion
We previously reported that ligation of integrins on the apical
surface of adhesion-competent trophoblast cells by FN initiates
intracellular Ca2+ signaling and upregulates FN-binding activity
(Wang et al., 2002). These biochemical events could be criticalFig. 6. Expression of PLC-γ1 and PLC-γ2 during preimplantation development. Egg
immunofluorescence using antibody against PLC-γ1 (A) or PLC-γ2 (B). Antigen w
immune rabbit IgG in place of primary antibody.for blastocyst adhesion to endometrial ECM during implanta-
tion and may modulate adhesive interactions with ECM
components as trophoblast cells pass through the basal lamina,
invade the decidua and remodel the uterine vascular system. We
now present evidence demonstrating that PLC transduces
outside-in signaling by integrins upstream to Ca2+ mobilization,
and that the responsible isozyme could be PLC-γ2.
Activation of integrins by ECM components frequently
initiates intracellular Ca2+ signaling (Ng-Sikorski et al., 1991;
Pardi et al., 1989; Smith et al., 1991; Pelletier et al., 1992;
Schwartz, 1993; Berk et al., 1995; Sjaastad et al., 1996; Ng-
Sikorski et al., 1991; Smith et al., 1991; Pelletier et al., 1992;
Schwartz, 1993; Berk et al., 1995; Sjaastad et al., 1996). We have
previously reported that RGD-containing peptides and ECM
components, as well as activating antibodies against αv, α5, β1
and β3 integrins, upregulate trophoblast adhesion to FN (Wang et
al., 2002). Since intracellular Ca2+ signaling is required for this
process, FN-120 could, in binding to these integrins, initiate Ca2+
influx through specific Ca2+ channels located on the apical
surface of adhesive trophoblast cells. Ligation of αvβ3 and α5β1
integrins by RGD-containing ECM components produces Ca2+
influx through L-type Ca2+ channels (Wu et al., 1998). However,s and embryos at the indicated stages were fixed, permeabilized and labeled by
as visualized and imaged as in Fig. 4, which shows a control stained with non-
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Fig. 7. Phosphorylation of PLC-γ1 and PLC-γ2 during exposure to FN-120. Adhesion-competent blastocysts cultured to GD7 were exposed to FN-120 for 0, 5, 15 or
30 min and then fixed, permeabilized and labeled by immunofluorescence using an antibody against either PLC-γ1 phosphorylated at tyrosine 783 or PLC-γ2
phosphorylated at tyrosine 1217. Panel A shows deconvolved images of embryos exposed to FN-120 for 0 or 5 min. Panel B shows the specific phospho-PLC staining
quantified as described in Materials and methods for each antibody over a 30 min period of exposure to FN-120. The mean±SEM is shown at each time for 10–12
embryos. *P<0.05, compared to Control.
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were unable to abolish the ability of FN-120 to elevate either
intracellular Ca2+ or FN-binding activity of peri-implantation
mouse blastocysts. Treatment with all channel blockers simulta-
neously was also without inhibitory effect (data not shown), and
general inhibition of Ca2+ influx by NiCl2 was ineffective,
arguing against the involvement of multiple channels that
compensate for one another. Therefore, Ca2+ influx does not
appear to participate in integrin-mediated Ca2+ signaling that
leads to strong adhesion of mouse blastocysts to FN.
Thapsigargin, which depletes the Ins(1,4,5)P3-sensitive
intracellular Ca2+ stores (Lewis and Cahalan, 1995), abolished
the ability of FN-120 to elevate intracellular Ca2+, while
depletion of stores regulated by the ryanodine receptor with
caffeine did not interfere. These findings indicate that
trophoblast adhesion to FN induces Ca2+ release from Ins
(1,4,5)P3 receptor-operated Ca
2+ stores, with or without
subsequent capacitative Ca2+ influx. The lack of inhibition by
NiCl2 suggests that capacitative Ca
2+ influx is not a requirement
for integrin signaling in this case, although it could facilitate
subsequent trophoblast development. A role for the Ins(1,4,5)P3
receptor in mobilizing intracellular Ca2+ was supported by the
observed inhibition by Xestospongin C. Production of Ins
(1,4,5)P3 depends on hydrolysis of phosphatidylinositol 4,5-
bisphosphate by PLC (Rhee and Bae, 1997; Rebecchi and
Pentyala, 2000; Rebecchi and Pentyala, 2000), which is acti-
vated by integrins in several cell types (Kanner et al., 1993;
Cybulsky et al., 1993). PLC activity was required for Ca2+
signaling and the upregulation of FN-binding activity in mouse
trophoblast cells, as demonstrated by specific inhibition with
U73122.Adhesion of fibroblasts to FN or treatment with monoclonal
antibodies against FN-binding integrins recruits PLC-γ into a
membrane-associated complex in a PTK-dependent manner
(Miyamoto et al., 1995). Activation of PLC-γ through tyrosine
phosphorylation occurs when platelets bind to collagen (Blake
et al., 1994; Ichinohe et al., 1995) and tyrosine phosphorylation
of PLC-γ is widely reported during integrin-mediated outside-
in signaling (Kanner et al., 1993; Blake et al., 1994; Ichinohe et
al., 1995; Blake et al., 1994; Ichinohe et al., 1995). When
activation of PLC is blocked using PTK inhibitors, both
intracellular Ca2+ signaling and strengthening of cell adhesion
are prevented (Ichinohe et al., 1995; Melford et al., 1997). In
peri-implantation blastocysts, inhibition of PTK activity
blocked the ability of FN-120 to elevate intracellular Ca2+
and upregulate FN-binding activity, which strongly favors a role
for PLC-γ in mediating integrin signaling by trophoblast cells
adhering to FN. Indeed, recent investigations have established a
central role for PLC-γ in the tyrosine kinase-based signaling
cascades that regulate cell adhesion via integrins (Jones et al.,
2005; Tvorogov et al., 2005; Watson et al., 2005). Depending
on cell type and the initiating signaling source, various PTKs
were found to participate in PLC-γ phosphorylation, as well as
upstream and downstream transduction of signaling. The
cytoplasmic PTK, Src, is required for activation of PLC-γ1 in
fibroblasts (Tvorogov et al., 2005) and a variety of other cell
types (Jones et al., 2005) cultured on fibronectin, laminin,
collagen or complex basement membrane, as well as in platelets
adhering to collagen or fibrinogen (Watson et al., 2005). Cell
and platelet spreading in response to integrin engagement,
which involves formation of lamellipodia, fails in the absence of
PLC-γ activation (Jones et al., 2005; Tvorogov et al., 2005;
151J. Wang et al. / Developmental Biology 302 (2007) 143–153McCarty et al., 2004; Wonerow et al., 2003). Strong adhesion to
FN at the apical surface of trophoblast cells appears to require
both PTK and PLC activities, and subsequently leads to cell
spreading and migration on the ECM. Our findings suggest that
invasive trophoblast differentiation requires the acquisition of
integrin signaling pathways that share many elements with other
cell types, particularly PLC-γ activation.
In adhesion-competent trophoblast cells, both PLC-β and
PLC-γ isoforms were expressed. The finding that suramin did
not interfere with upregulation of FN-binding activity
diminishes the likelihood of a role in this pathway for PLC-β
or other PLC isoforms activated by heterotrimeric G proteins.
Suramin inhibits GDP-GTP exchange, the rate limiting step in
the activation of Gα-subunits, making it a fairly broad inhibitor
of heterotrimeric G proteins (Freissmuth et al., 1996). Suramin
has poor specificity in that it can inhibit other signaling
molecules, but its lack of effect on FN-binding activity supports
the interpretation that Gα proteins are not involved. However,
we cannot exclude the possible involvement of suramin-
resistant PLC isozymes that are activated by small GTPases.
Due to complex crosstalk, it is conceivable, for example, that
PLC-ε could be activated by Ras family GTPases downstream
of PTK (Harden and Sondek, 2006). Rho expression and
function have been reported as early as the 8-cell stage during
mouse development (Clayton et al., 1999). The small GTPases
Rho, Rac and Cdc42 are all highly expressed by rat Rcho-1
choriocarcinoma cells and mouse secondary trophoblast giant
cells, and appear to be developmentally regulated during
trophoblast differentiation (Parast et al., 2001; El Hashash and
Kimber, 2006). At this time, the expression of additional PLC
isoforms by mouse blastocysts and the role of small GTPases in
the upregulation of FN-binding activity are unknown.
The pattern of the expression of both PLC-γ1 and PLC-γ2
during preimplantation development has not previously been
investigated, although it is known that both isozymes are
expressed in mouse eggs (Mehlmann et al., 1998).We report that
the relative levels of both isozymes decrease at the blastocyst
stage, a pattern suggesting that both are initially maternal gene
products. In adhesion-competent trophoblast cells of late stage
blastocysts, levels of PLC-γ2 specifically increased, although
both isozymes were detectable. Unlike PLC-γ1, which was
distributed primarily within the cytoplasm, and PLC-β1, which
localized near cell–cell junctions, PLC-γ2 was located near the
apical surface of trophoblast cells. Therefore, PLC-γ2 was
strongly expressed in the vicinity of integrins that mediate blast-
ocyst interaction with maternal ECM. Activation of PLC-γ2
immediately after exposure to FN-120 was established by
monitoring its phosphorylation at tyrosine 1217. No evidence of
PLC-γ1 phosphorylation was found using antibodies from two
commercial sources that recognize an epitope containing
phosphorylated tyrosine at position 783. We conclude that
PLC-γ2 is a prime candidate to mediate FN-induced Ca2+
signaling required for strong adhesion to FN during blastocyst
implantation.
Knockout of the PLC-γ1 gene in mice causes significant
embryonic growth retardation, although no specific systemic
defects were noted (Ji et al., 1997). Interestingly, developmentaldefects, including embryonic death, occur only after GD 8.5,
and no placental defects were described. PLC-γ2 deficient mice
are viable and apparently have a normal implantation phenotype
(Wang et al., 2000a). The possibility that the two PLC-γ
isozymes are able to compensate for one another during
implantation has not been investigated and no information is yet
available regarding a double knockout. Signaling molecules that
regulate integrin-mediated adhesion are numerous and fre-
quently have overlapping functions, reducing the likelihood that
deletion of a single component will generate a phenotype
(Watson et al., 2005). Within the endometrium, the blastocyst
encounters a complex matrix that contains not just FN, but
numerous components. We have examined FN as an archetyp-
ical ECM component, demonstrating its ability to precipitate
intracellular signaling that directs invasive trophoblast differ-
entiation. It remains to be determined whether this response is
typical of interaction with other ECM components or if there is
diversity among the effects of each element to fine tune
trophoblast phenotype.
Our study strongly suggests a critical role for PLC-γ in FN-
mediated intracellular Ca2+ signaling that leads to strengthening
of trophoblast adhesion to FN. A deeper understanding of the
developmental mechanism that controls blastocyst implantation
awaits elaboration of the molecular cascade that regulates PLC-
γ activity in trophoblast cells. The biochemical data presented
here clearly indicate that PLC-γ activity plays a major role in
early trophoblast differentiation and its conversion to an
invasive phenotype as directed through interactions with
endometrial ECM components.
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